CNBC.com's News Now: Buffett's $5B Investment in Goldman

To view the latest headlines and get real-time stock quotes on your mobile device, go to http://m.cnbc.com

	DOW	10825.17		-29.00	-0.27%
	NASDAQ	2155.68		2.35	+0.11%
	S&P 500	1185.87		-2.35	-0.2%

Wednesday, Sep. 24, 2008

1. Buffett's $5B Investment in Goldman: Berkshire Hathaway's Warren Buffett discusses his move - seen as a big vote of confidence in our financial system. 2. Executive Comp Limits ? CNBC's Charlie Gasparino has details on executive compensation limits that may be in a financial sector bailout plan. 3. Stop Trading!: Playing Politics With Paulson's Plan: As Treasury Secretary Henry Paulson and Federal Reserve Chairman Ben Bernanke go before Congress this afternoon, Washington's beginning to play politics with Paulson's plan. Cramer took that up the issue during Wednesday's Stop Trading! 4. Rep. Watt Questions Paulson, Bernanke: Rep. Melvin Watt, D-N.C. questions Treasury Secretary Hank Paulson and Fed Chairman Ben Bernanke on the proposed plan to bail out the financial sector. 5. Maria's Market Message: CNBC's Maria Bartiromo discusses the day's top business and financial stories, and looks ahead to tomorrow's Closing Bell. Bad Auto Loans: Should They Be Bailed Out Too? It seems like everyone is targeting the credit crunch as the main issue hurting the auto industry. Click here to read more.

WEALTH IN AMERICA, NBC/WSJ POLLING THE NATION: CNBC latest "Wealth in America" survey takes the pulse of the economy and gets a reading of what holiday spending is likely to be this year. Steve Liesman rolls out the results. John Harwood will also break down the new NBC/WSJ poll on the state of politics and the economy. THE MAN WHO SHORTED SUBPRIME: Jane Wells catches up (again) with Jeff Greene, the investor who made half a billion dollars shorting subprime. Jeff talks about what caused him some sleepless nights in the last week and what new investments he's diving into. NOT SOLD ON STENTS: Mike Huckman follows a big new study showing stents are not worth the price. In many cases, old-fashioned heart drugs provide the same benefit for much less money. Approximately 800,000 stent procedures are done each year in the U.S. at a cost of about $10 billion. What's the market reaction? RIMM EARNINGS: Research In Motion reports quarterly earnings after-the-bell, and Jim Goldman looks at the buzz surrounding the Blackberry-maker. With the delay of its hotly-anticipated Bold, will there be more bad news? Portfolio Watchlist Insider Trends Financial Glossary Stock Screeners Fund Screeners Earnings Screeners

To unsubscribe to this email click here If this e-mail was forwarded to you and you would like to subscribe to CNBC.com's News Now mailing, please click here